Description
Inferno is a research peptide blend (5 mL) combining AOD-9604, CJC-1295, Ipamorelin, MOTS-C, dosed at 10/6/10/10 mg in the listed order. Component research areas: Fat metabolism; GH release; GH release; mitochondrial/insulin sensitivity. See each individual compound page for full detail. For research use only; not FDA-approved.
